Attached files

file filename
EX-99.2 - EX-99.2 - KINDRED HEALTHCARE, INCd133599dex992.htm
8-K - FORM 8-K - KINDRED HEALTHCARE, INCd133599d8k.htm
LOGO    EXHIBIT 99.1

 

Contact:    Todd Flowers
   Investor Relations
   (502) 596-6569

KINDRED HEALTHCARE REPORTS FOURTH QUARTER 2015 RESULTS

 

 

Consolidated Revenues of $1.8 billion, Core EBITDAR of $248 million(1),

Core Diluted EPS from Continuing Operations of $0.33(1) and

Adjusted Core Diluted EPS from Continuing Operations of $0.44(1) in the Fourth Quarter;

GAAP Diluted EPS from Continuing Operations of $0.50 and EBITDAR of $198 million(1) in the Fourth Quarter

Includes Costs of $51 million and an Income Tax Benefit of $66 million

Related to Litigation, Transaction, Integration, Impairment and Other Restructuring Costs

 

 

Consolidated Revenues of $7.1 billion, Core EBITDAR of $980 million(1), Core Diluted EPS from Continuing Operations

of $1.28(1) and Adjusted Core Diluted EPS from Continuing Operations of $1.70(1) for the Year

GAAP Diluted Loss Per Share of $1.12 and EBITDAR of $675 million(1) for the Year

Significant Core Operating Cash Flows of $318 million(1)(2) for the Year

GAAP Operating Cash Flows of $163 million for the Year

 

 

Company Establishes Full Year Outlook for 2016

LOUISVILLE, Ky. (February 25, 2016) – Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced its operating results for the fourth quarter ended December 31, 2015.

Benjamin A. Breier, President and Chief Executive Officer of the Company, commented, “Throughout 2015, our focus at Kindred has been growing and transforming our operations and clinical capabilities to expand our national leadership in post-acute care and I am proud of our team’s significant accomplishments. We successfully completed and integrated two highly strategic transactions, Gentiva Health Services, Inc. (“Gentiva”) and Centerre Healthcare Corporation (“Centerre”), which together added more than $2 billion in revenues, 40,000 employees and 500 sites of service to our platform.

Mr. Breier added, “These transactions have strengthened our ability to deliver a full continuum of post-acute care, while also contributing operating results and cost synergies that exceeded our expectations. Gentiva and Centerre also accelerated the transformation of Kindred’s financial profile, such that today the Company is more focused than ever on higher growth, lower capital intensity businesses that generate substantial free cash flows.”

Mr. Breier continued, “Solid execution in each of our businesses remains our top priority as we drive effective patient-centered care solutions and adapt to change. We are confident that Kindred’s full continuum of post-acute services, which enables us to deliver care and services where and when patients need them the most, and our innovations in care management uniquely position us to successfully transition to a value-based healthcare system. As always, I thank the many stakeholders in Kindred, and especially our 102,000 teammates, for the exceptional care they provide to more than a million patients each year.”

All financial and statistical information included in this press release reflects the continuing operations of the Company’s businesses for all periods presented unless otherwise indicated. The acquisitions of Gentiva and Centerre have been included in the operating results presented since the respective dates of acquisition.

 

(1) See reconciliation of core results to generally accepted accounting principles (“GAAP”) results beginning on page 12, including a reconciliation of core EBITDAR and EBITDAR to the most comparable GAAP measure, income from continuing operations, of $56.0 million for the fourth quarter of 2015 and a loss from continuing operations of $51.9 million for the year ended December 31, 2015.
(2) Core operating cash flows, similar to the GAAP presentation, include net changes in working capital and exclude routine capital expenditures and distributions to noncontrolling interests.

 

– MORE –

680 South Fourth Street        Louisville, Kentucky 40202

502.596.7300        www.kindredhealthcare.com


Kindred Healthcare Reports Fourth Quarter 2015 Results

Page 2

February 25, 2016

 

 

Fourth Quarter and Year Consolidated Highlights(1):

 

    Consolidated revenues for the fourth quarter increased 40.8% to $1.78 billion year-over-year and core earnings before interest, income taxes, depreciation, amortization, rent and certain charges (“core EBITDAR”) increased 45.7% to $248 million compared to the same period in 2014. For the year, consolidated revenues increased 40.3% to $7.1 billion and core EBITDAR increased 43.3% to $980 million, each as compared to the same period last year. A significant driver of the growth in both periods was the acquisition of Gentiva and Centerre.

 

    Core diluted earnings per share (“EPS”) from continuing operations for the fourth quarter was $0.33 and adjusted core diluted EPS from continuing operations was $0.44 based upon 87.2 million weighted average diluted shares, an improvement compared to core diluted EPS of $0.26 and adjusted core diluted EPS of $0.38 for the same period a year ago based upon 63.2 million weighted average diluted shares. For the year, core diluted EPS from continuing operations was $1.28 and adjusted core diluted EPS from continuing operations was $1.70 based upon 86.1 million weighted average diluted shares, an improvement compared to core diluted EPS of $1.06 and adjusted core diluted EPS of $1.51 for the same period a year ago based upon 58.2 million weighted average diluted shares.

 

    The Company generated core operating cash flows of $54 million(2) for the fourth quarter compared to $86 million(2) for the same period a year ago, and core free cash flows were $2 million(3) for the fourth quarter compared to $58 million(3) in the same period of 2014. The decline in both measures was attributable to the timing of certain year-end payroll expenditures in the fourth quarter of 2015 and a meaningful acceleration of accounts receivable collections in the fourth quarter of 2014 in the Hospital Division after the completion of central business office consolidations. Core free cash flows for the fourth quarter of 2015 were also negatively impacted by the timing of routine capital expenditures as compared to a year ago.

For the year, core operating cash flows were $318 million(2) compared to $188 million(2) for the same period a year ago, and core free cash flows were $154 million(3) compared to $83 million(3) in the same period of 2014. These results reflect the Company’s changing business mix primarily driven by the addition of Gentiva and Centerre in 2015.

 

    GAAP operating results:

 

     Three months ended      Year ended  
     December 31,      December 31,  
     2015      2014      2015      2014  
     (In thousands, except per share amounts)  

Diluted earnings (loss) per share from continuing operations

   $ 0.50       $ (0.15    $ (1.12    $ (0.24

Income (loss) from continuing operations

     55,984         (4,803      (51,863      4,896   

Operating cash flows

     70,195         81,149         163,262         105,471   

 

    The Kindred Board of Directors declared a cash dividend of $0.12 per share on the Company’s common stock payable on April 1, 2016 to shareholders of record as of the close of business on March 10, 2016.

Fourth Quarter Segment Highlights(1)(4):

Kindred’s Hospital Division fourth quarter same-hospital revenues declined 3.3% over the prior year period to $594 million, with a decline in same-hospital admissions of 3.3% compared to the same period last year. Sequentially, same-hospital admissions increased 1.7% and same-hospital revenues per patient day increased 2.8% compared to the third quarter of 2015. Core EBITDAR for the fourth quarter declined to $118 million from $135 million a year ago, and increased from $97 million in the third quarter of 2015.

 

(1) See reconciliation of core results to GAAP results beginning on page 12.
(2) Core operating cash flows, similar to the GAAP presentation, include net changes in working capital and exclude routine capital expenditures and distributions to noncontrolling interests.
(3) Core free cash flows include net changes in working capital, routine capital expenditures and distributions to noncontrolling interests.
(4) See same-hospital and full segment data on pages 8 and 9.

 

- MORE -


Kindred Healthcare Reports Fourth Quarter 2015 Results

Page 3

February 25, 2016

 

 

Kindred at Home Division fourth quarter revenues and core EBITDAR increased to $604 million and $99 million, respectively. The home health segment experienced another quarter of solid growth, with episodic admissions increasing 1.5% and revenues increasing 4.8% to $358 million, both over the prior year period on a combined basis, notwithstanding a 12.6% consolidation of home health branches during 2015 from 427 to 373 sites. Average home health revenue per branch grew 18.0% during the course of this consolidation. The hospice segment generated $178 million of revenues with stable admissions during a seasonally weak quarter. Average hospice revenue per branch increased 13.8% as the Company consolidated the hospice branch network from 193 sites at the end of 2014 to 175 sites at the end of 2015.

Kindred Rehabilitation Services Division revenues increased 4.8% to $362 million and core EBITDAR contribution increased 42.7% to $57 million for the quarter. The Kindred Hospital Rehabilitation Services segment experienced strong revenue growth of $63 million or 67.4% over the prior year period, due to the successful integration of Centerre, and achieved core EBITDAR margin improvement from 25.7% to 29.0%. The RehabCare segment (“RHB”) revenues declined to $207 million from $253 million a year ago primarily due to contract losses that occurred in the first half of 2015. Excluding one customer with 23 sites of service that RHB terminated in the fourth quarter of 2015 in connection with litigation to collect past due amounts, RHB added 32 net new sites of service over the last half of 2015.

Kindred’s Nursing Center Division revenues grew 0.6% to $273 million in the fourth quarter. Core EBITDAR was $37 million, down $2 million from a year ago. Top line growth was driven by a 3.5% improvement in revenue per patient day, including a 4.9% increase in Medicaid revenue per patient day that was partially offset by a 3.9% admission decline. Operating costs per patient day increased 4.8% in the fourth quarter, primarily a result of the admissions decline, start-up costs for January 2016 new openings and continuing Medicare length of stay contraction.

2016 Outlook

Kindred today announced its outlook for 2016. Kindred expects:

 

    Annual revenues of approximately $7.250 billion, with a range of $7.2 billion to $7.3 billion

 

    Core EBITDAR of approximately $990 million, with a range of $970 million to $1.010 billion

 

    Core diluted EPS from continuing operations of approximately $0.90, with a range of $0.80 to $1.00(1)

 

    Adjusted core diluted EPS from continuing operations of approximately $1.25, with a range of $1.15 to $1.35(1)(2)

For the first quarter of 2016, the Company expects core EBITDAR to approximate $235 million to $250 million, core diluted EPS from continuing operations to approximate $0.17 to $0.27 and adjusted core diluted EPS from continuing operations to approximate $0.26 to $0.36.

Mr. Breier commented, “Our outlook reflects what we believe will be a transition period for our Hospital Division in 2016 and 2017 due to long-term acute care (“LTAC”) criteria implementation. We anticipate that over time, our LTAC criteria mitigation efforts, robust growth in other divisions, and strong cost management across the enterprise will offset the effects of these reimbursement changes. For the enterprise, we expect stable and consistent core EBITDAR of approximately $1 billion in 2016 and at least $1 billion in 2017. Throughout this transition period we expect to continue generating roughly $300 million(3) per year in core operating cash flows, and approximately half of that amount in core free cash flows(4).

Mr. Breier concluded, “Our extensive efforts to grow and diversify Kindred enable us to work through challenges within any individual business, while continuing to advance the enterprise. We will continue to invest in strategic growth, including a particular focus on investments that help to increase our capabilities as a post-acute benefits management company, preparing us for the ongoing transition from fee-for-service to fee-for-value. The substantial cash flows we expect from our diversified service offerings will allow us to continue investing aggressively in our platform, which will drive growth, reduce our leverage, and advance our Continue the Care strategy. The growth in our Kindred at Home division and Kindred Hospital Rehabilitation Services in 2015, our recent announcements regarding expansion in four integrated markets and our strategic partnership with Inovalon (NASDAQ:INOV) to create a unique set of post-acute benefits management tools and solutions are examples of these capabilities.”

 

(1) The EPS estimate is based upon an estimated weighted average annual diluted share count for 2016 of 88.5 million shares.
(2) Adjusted core diluted EPS is calculated by excluding non-cash expenses, net of the income tax benefit, related to amortization of intangible assets, stock-based compensation and deferred financing costs, from core income from continuing operations. The estimated non-cash expenses for 2016 total approximately $53 million ($32 million net of income taxes) or approximately $0.35 per diluted share.
(3) Core operating cash flows, similar to the GAAP presentation, include net changes in working capital and exclude routine capital expenditures and distributions to noncontrolling interests.
(4) Core free cash flows include net changes in working capital, routine capital expenditures and distributions to noncontrolling interests.

 

- MORE -


Kindred Healthcare Reports Fourth Quarter 2015 Results

Page 4

February 25, 2016

 

 

This outlook excludes transaction costs, the effect of any reimbursement changes, debt refinancing costs, severance, retirement, retention, consulting and restructuring costs, litigation and related contingency expense, integration costs, any further acquisitions or divestitures, any impairment charges, any further issuances of common stock or any repurchases of common stock.

All forward-looking non-GAAP financial measures contained in this section “2016 Outlook” are provided only on a non-GAAP basis. This is due to the inherent difficulty of forecasting the timing or amount of items that would be included in the most directly comparable forward-looking GAAP financial measures. As a result, reconciliation of the forward-looking non-GAAP financial measures to GAAP financial measures is not available without unreasonable effort and the Company is unable to address the probable significance of the unavailable information.

Cash Dividend

The Company announced that its Board of Directors has approved the payment of a cash dividend of $0.12 per share of common stock to be paid on April 1, 2016 to shareholders of record as of the close of business on March 10, 2016.

Conference Call

As previously announced, investors and the general public may access a live webcast of the fourth quarter 2015 conference call through a link on the Company’s website at http://investors.kindredhealthcare.com. The conference call will be held on February 26 at 10:00 a.m. (Eastern Time).

A telephone replay of the conference call will become available at approximately 1:00 p.m. on February 26 by dialing (719) 457-0820, access code: 4866232. The replay will be available through March 7.

Forward-Looking Statements and Non-GAAP Reconciliations

See page 11 for important disclosures regarding the Company’s forward-looking statements and the non-GAAP financial reconciliations that follow.

About Kindred Healthcare

Kindred Healthcare, Inc., a top-90 private employer in the United States, is a FORTUNE 500 healthcare services company based in Louisville, Kentucky with annual revenues of approximately $7.2 billion(1). At December 31, 2015, Kindred through its subsidiaries had approximately 102,000 employees providing healthcare services in 2,692 locations in 46 states, including 95 transitional care hospitals, 18 inpatient rehabilitation hospitals, 90 nursing centers, 19 sub-acute units, 604 Kindred at Home home health, hospice and non-medical home care sites of service, 100 inpatient rehabilitation units (hospital-based) and a contract rehabilitation services business, RehabCare, which served 1,766 non-affiliated sites of service. Ranked as one of Fortune magazine’s Most Admired Healthcare Companies for seven years, Kindred’s mission is to promote healing, provide hope, preserve dignity and produce value for each patient, resident, family member, customer, employee and shareholder we serve. For more information, go to www.kindredhealthcare.com. You can also follow us on Twitter and Facebook.

 

(1) Revenues were computed by combining the twelve months ended December 31, 2015 data for Kindred and one month ended January 2015 data for Gentiva.

 

- MORE -


Kindred Healthcare Reports Fourth Quarter 2015 Results

Page 5

February 25, 2016

 

 

KINDRED HEALTHCARE, INC.

Condensed Consolidated Statement of Operations

(In thousands, except per share amounts)

 

     Three months ended     Year ended  
     December 31,     December 31,  
     2015     2014     2015     2014  

Revenues

   $ 1,780,949      $ 1,264,674      $ 7,054,907      $ 5,027,599   
  

 

 

   

 

 

   

 

 

   

 

 

 

Salaries, wages and benefits

     909,171        616,277        3,614,091        2,442,879   

Supplies

     96,295        73,774        384,354        289,043   

Rent

     97,823        79,167        382,609        313,039   

Other operating expenses

     208,315        168,206        825,996        679,992   

General and administrative expenses

     344,340        259,702        1,395,288        973,223   

Other income

     (1,317     (278     (3,016     (872

Litigation contingency expense

     8,261        —          138,648        4,600   

Impairment charges

     18,031        —          24,757        —     

Depreciation and amortization

     40,362        38,558        157,251        155,570   

Interest expense

     56,267        39,919        232,395        168,763   

Investment income

     (603     (1,021     (2,806     (3,996
  

 

 

   

 

 

   

 

 

   

 

 

 
     1,776,945        1,274,304        7,149,567        5,022,241   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

     4,004        (9,630     (94,660     5,358   

Provision (benefit) for income taxes

     (51,980     (4,827     (42,797     462   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations

     55,984        (4,803     (51,863     4,896   

Discontinued operations, net of income taxes:

        

Income (loss) from operations

     1,509        (28,743     (235     (53,630

Gain (loss) on divestiture of operations

     261        (9,061     1,244        (12,698
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from discontinued operations

     1,770        (37,804     1,009        (66,328
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

     57,754        (42,607     (50,854     (61,432

(Earnings) loss attributable to noncontrolling interests:

        

Continuing operations

     (12,082     (5,143     (42,564     (18,872

Discontinued operations

     2        66        34        467   
  

 

 

   

 

 

   

 

 

   

 

 

 
     (12,080     (5,077     (42,530     (18,405
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) attributable to Kindred

   $ 45,674      $ (47,684   $ (93,384   $ (79,837
  

 

 

   

 

 

   

 

 

   

 

 

 

Amounts attributable to Kindred stockholders:

        

Income (loss) from continuing operations

   $ 43,902      $ (9,946   $ (94,427   $ (13,976

Income (loss) from discontinued operations

     1,772        (37,738     1,043        (65,861
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ 45,674      $ (47,684   $ (93,384   $ (79,837
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings (loss) per common share:

        

Basic:

        

Income (loss) from continuing operations

   $ 0.50      $ (0.15   $ (1.12   $ (0.24

Discontinued operations:

        

Income (loss) from operations

     0.02        (0.44     —          (0.91

Gain (loss) on divestiture of operations

     —          (0.14     0.01        (0.21
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from discontinued operations

     0.02        (0.58     0.01        (1.12
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ 0.52      $ (0.73   $ (1.11   $ (1.36
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted:

        

Income (loss) from continuing operations

   $ 0.50      $ (0.15   $ (1.12   $ (0.24

Discontinued operations:

        

Income (loss) from operations

     0.02        (0.44     —          (0.91

Gain (loss) on divestiture of operations

     —          (0.14     0.01        (0.21
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from discontinued operations

     0.02        (0.58     0.01        (1.12
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ 0.52      $ (0.73   $ (1.11   $ (1.36
  

 

 

   

 

 

   

 

 

   

 

 

 

Shares used in computing earnings (loss) per common share:

        

Basic

     86,336        65,135        84,558        58,634   

Diluted

     87,232        65,135        84,558        58,634   

Cash dividends declared and paid per common share

   $ 0.12      $ 0.12      $ 0.48      $ 0.48   

 

- MORE -


Kindred Healthcare Reports Fourth Quarter 2015 Results

Page 6

February 25, 2016

 

 

KINDRED HEALTHCARE, INC.

Condensed Consolidated Balance Sheet

(In thousands, except per share amounts)

 

     December 31,     December 31,  
     2015     2014  
ASSETS     

Current assets:

    

Cash and cash equivalents

   $ 98,758      $ 164,188   

Insurance subsidiary investments

     106,638        99,951   

Accounts receivable less allowance for loss

     1,194,868        944,219   

Inventories

     27,791        25,702   

Income taxes

     11,790        8,575   

Interest deposit on senior unsecured notes held in escrow

     —          23,438   

Other

     61,054        41,598   
  

 

 

   

 

 

 
     1,500,899        1,307,671   

Property and equipment

     2,162,398        1,978,153   

Accumulated depreciation

     (1,190,402     (1,076,049
  

 

 

   

 

 

 
     971,996        902,104   

Goodwill

     2,669,810        997,597   

Intangible assets less accumulated amortization

     755,655        400,700   

Assets held for sale

     613        3,475   

Insurance subsidiary investments

     204,498        166,045   

Deferred tax assets

     104,130        93,565   

Proceeds from senior unsecured notes held in escrow

     —          1,350,000   

Acquisition deposit

     18,489        195,000   

Other

     292,846        236,807   
  

 

 

   

 

 

 

Total assets

   $ 6,518,936      $ 5,652,964   
  

 

 

   

 

 

 
LIABILITIES AND EQUITY     

Current liabilities:

    

Accounts payable

   $ 187,061      $ 175,725   

Salaries, wages and other compensation

     404,925        358,857   

Due to third party payors

     36,251        43,957   

Professional liability risks

     64,099        64,137   

Other accrued liabilities

     394,246        189,980   

Long-term debt due within one year

     24,630        24,607   
  

 

 

   

 

 

 
     1,111,212        857,263   

Long-term debt

     3,137,025        2,852,531   

Professional liability risks

     263,273        243,614   

Deferred credits and other liabilities

     301,379        213,584   

Equity:

    

Stockholders’ equity:

    

Common stock, $0.25 par value; authorized 175,000 shares; issued 83,792 shares - December 31, 2015 and 69,977 shares - December 31, 2014

     20,948        17,494   

Capital in excess of par value

     1,737,747        1,586,692   

Accumulated other comprehensive loss

     (2,632     (2,551

Accumulated deficit

     (256,209     (159,768
  

 

 

   

 

 

 
     1,499,854        1,441,867   

Noncontrolling interests

     206,193        44,105   
  

 

 

   

 

 

 

Total equity

     1,706,047        1,485,972   
  

 

 

   

 

 

 

Total liabilities and equity

   $ 6,518,936      $ 5,652,964   
  

 

 

   

 

 

 

 

- MORE -


Kindred Healthcare Reports Fourth Quarter 2015 Results

Page 7

February 25, 2016

 

 

KINDRED HEALTHCARE, INC.

Condensed Consolidated Statement of Cash Flows

(In thousands)

 

     Three months ended
December 31,
    Year ended
December 31,
 
     2015     2014     2015     2014  

Cash flows from operating activities:

        

Net income (loss)

   $ 57,754      $ (42,607   $ (50,854   $ (61,432

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

        

Depreciation and amortization

     40,853        39,145        158,374        160,950   

Amortization of stock-based compensation costs

     4,872        6,986        20,636        16,643   

Amortization of deferred financing costs

     3,566        2,077        13,721        23,288   

Payment of capitalized lender fees related to debt issuance

     —          (3,527     (28,012     (22,652

Provision for doubtful accounts

     22,643        6,215        52,460        41,803   

Deferred income taxes

     (45,738     (24,341     (46,632     (35,615

Impairment charges

     18,031        —          24,757        673   

(Gain) loss on divestiture of discontinued operations

     (261     9,061        (1,244     12,698   

Other

     3,080        47        13,537        2,336   

Change in operating assets and liabilities:

        

Accounts receivable

     4,822        28,125        (8,577     (74,378

Inventories and other assets

     10,312        (13,074     54,493        (25,960

Accounts payable

     2,408        13,070        (10,380     (9,399

Income taxes

     (6,254     12,959        27,392        31,728   

Due to third party payors

     (26,917     (3,363     (30,882     11,177   

Other accrued liabilities

     (18,976     50,376        (25,527     33,611   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by operating activities

     70,195        81,149        163,262        105,471   
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from investing activities:

        

Routine capital expenditures

     (41,240     (23,656     (121,931     (91,081

Development capital expenditures

     (7,865     (2,564     (19,931     (5,257

Acquisitions, net of cash acquired

     —          —          (673,547     (24,136

Acquisition deposit

     (18,489     (195,000     176,511        (195,000

Sale of assets

     1,674        952        8,735        23,861   

Proceeds from senior unsecured notes offering held in escrow

     —          (1,350,000     1,350,000        (1,350,000

Interest in escrow for senior unsecured notes

     —          (23,438     23,438        (23,438

Purchase of insurance subsidiary investments

     (26,036     (7,930     (85,222     (105,324

Sale of insurance subsidiary investments

     24,295        16,749        75,075        51,716   

Net change in insurance subsidiary cash and cash equivalents

     (3,875     (20,689     (12,271     33,683   

Proceeds from note receivable

     —          —          25,000        —     

Net change in other investments

     (4,995     379        (4,620     1,406   

Other

     592        1,216        10,972        679   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) investing activities

     (75,939     (1,603,981     752,209        (1,682,891
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from financing activities:

        

Proceeds from borrowings under revolving credit

     325,600        83,000        1,740,450        1,551,515   

Repayment of borrowings under revolving credit

     (312,000     (83,000     (1,631,850     (1,807,615

Proceeds from issuance of term loan, net of discount

     —          —          199,000        997,500   

Proceeds from issuance of senior unsecured notes due 2022

     —          —          —          500,000   

Proceeds from issuance of senior unsecured notes due 2020 and 2023

     —          1,350,000        —          1,350,000   

Proceeds from issuance of debt component of tangible equity units

     —          34,773        —          34,773   

Repayment of Gentiva debt

     —          —          (1,177,363     —     

Repayment of senior unsecured notes

     —          —          —          (550,000

Repayment of term loan

     (3,002     (2,500     (12,010     (788,563

Repayment of other long-term debt

     (5,352     (58     (6,752     (273

Payment of deferred financing costs

     (162     (279     (3,446     (3,431

Equity offering, net of offering costs

     —          101,615        —          321,968   

Issuance of equity component of tangible equity units, net of issuance costs

     —          133,336        —          133,336   

Issuance of common stock in connection with employee benefit plans

     —          26        534        6,243   

Payment of costs associated with issuance of common stock and tangible equity units

     —          —          (915     —     

Payment of dividend for mandatory redeemable preferred stock

     (2,752     —          (10,887     —     

Dividends paid

     (10,052     (7,754     (40,119     (28,594

Contributions made by noncontrolling interests

     660        —          2,152        —     

Distributions to noncontrolling interests

     (10,635     (4,088     (42,458     (13,692

Other

     1,306        165        2,763        2,469   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     (16,389     1,605,236        (980,901     1,705,636   
  

 

 

   

 

 

   

 

 

   

 

 

 

Change in cash and cash equivalents

     (22,133     82,404        (65,430     128,216   

Cash and cash equivalents at beginning of period

     120,891        81,784        164,188        35,972   
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 98,758      $ 164,188      $ 98,758      $ 164,188   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

- MORE -


Kindred Healthcare Reports Fourth Quarter 2015 Results

Page 8

February 25, 2016

 

 

KINDRED HEALTHCARE, INC.

Condensed Consolidated and Business Segment Data (a)

(Unaudited)

(In thousands, except per share amounts)

 

    2014 Quarters           2015 Quarters           Fourth quarter
% change v.
 
    First     Second     Third     Fourth     Year     First     Second     Third     Fourth     Year     prior year  

Consolidated income statement data:

                     

Revenues

  $ 1,272,610      $ 1,261,397      $ 1,228,918      $ 1,264,674      $ 5,027,599      $ 1,675,967      $ 1,833,475      $ 1,764,516      $ 1,780,949      $ 7,054,907        40.8   

Core EBITDAR

  $ 181,044      $ 175,865      $ 157,218      $ 170,088      $ 684,215      $ 234,211      $ 261,800      $ 236,477      $ 247,839      $ 980,327        45.7   

Rent

    78,530        77,452        77,643        79,167        312,792        91,199        95,528        95,436        96,934        379,097        22.4   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Core EBITDA

    102,514        98,413        79,575        90,921        371,423        143,012        166,272        141,041        150,905        601,230        66.0   

Depreciation and amortization

    39,092        39,172        38,748        38,558        155,570        38,935        38,625        39,329        40,362        157,251        4.7   

Interest, net

    25,617        21,438        22,171        21,857        91,083        44,346        56,140        56,008        55,664        212,158        154.7   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Income from continuing operations before income taxes

    37,805        37,803        18,656        30,506        124,770        59,731        71,507        45,704        54,879        231,821        79.9   

Provision for income taxes

    14,445        13,612        6,168        8,471        42,696        22,466        25,721        15,298        13,758        77,243        62.4   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Income from continuing operations

    23,360        24,191        12,488        22,035        82,074        37,265        45,786        30,406        41,121        154,578        86.6   

Noncontrolling interests

    (4,529     (4,828     (4,372     (5,143     (18,872     (8,847     (11,735     (9,900     (12,082     (42,564     134.9   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Net income attributable to Kindred

  $ 18,831      $ 19,363      $ 8,116      $ 16,892      $ 63,202      $ 28,418      $ 34,051      $ 20,506      $ 29,039      $ 112,014        71.9   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Core diluted EPS

  $ 0.35      $ 0.35      $ 0.13      $ 0.26      $ 1.06      $ 0.34      $ 0.39      $ 0.23      $ 0.33      $ 1.28        26.9   

Adjusted Core EPS

  $ 0.46      $ 0.50      $ 0.20      $ 0.38      $ 1.51      $ 0.43      $ 0.51      $ 0.33      $ 0.44      $ 1.70        15.8   

Diluted shares

    52,711        53,792        62,902        63,163  (b)      58,210  (b)      82,422        86,402        86,892        87,232        86,098        38.1   

Revenues by segment:

                     

Hospital division

  $ 627,245      $ 612,517      $ 591,121      $ 619,185      $ 2,450,068      $ 640,483      $ 627,206      $ 579,497      $ 593,593      $ 2,440,779        (4.1

Kindred at Home:

                     

Home health

    74,791        75,502        74,026        74,588        298,907        300,867        427,820        424,054        425,759        1,578,500        470.8   

Hospice

    12,913        12,484        12,160        12,538        50,095        119,057        178,005        181,140        178,325        656,527        1,322.3   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   
    87,704        87,986        86,186        87,126        349,002        419,924        605,825        605,194        604,084        2,235,027        593.3   

Kindred Rehabilitation Services:

                     

Kindred Hospital Rehabilitation Services

    93,177        94,963        93,139        92,922        374,201        151,564        152,544        149,435        155,579        609,122        67.4   

RehabCare

    253,943        253,694        246,732        252,667        1,007,036        252,595        236,791        219,518        206,582        915,486        (18.2
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   
    347,120        348,657        339,871        345,589        1,381,237        404,159        389,335        368,953        362,161        1,524,608        4.8   

Nursing center division

    262,590        264,437        263,897        271,625        1,062,549        274,308        273,870        270,510        273,387        1,092,075        0.6   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   
    1,324,659        1,313,597        1,281,075        1,323,525        5,242,856        1,738,874        1,896,236        1,824,154        1,833,225        7,292,489        38.5   

Eliminations

    (52,049     (52,200     (52,157     (58,851     (215,257     (62,907     (62,761     (59,638     (52,276     (237,582     (11.2
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   
  $ 1,272,610      $ 1,261,397      $ 1,228,918      $ 1,264,674      $ 5,027,599      $ 1,675,967      $ 1,833,475      $ 1,764,516      $ 1,780,949      $ 7,054,907        40.8   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Core EBITDAR by segment:

                     

Hospital division

  $ 139,505      $ 131,990      $ 117,604      $ 134,791      $ 523,890      $ 134,786      $ 131,532      $ 97,128      $ 117,675      $ 481,121        (12.7

Kindred at Home:

                     

Home health

    2,845        5,769        5,961        7,398        21,973        46,798        72,917        68,155        68,826        256,696        830.3   

Hospice

    1,852        2,139        1,149        524        5,664        16,996        27,887        34,025        30,212        109,120        5,665.6   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   
    4,697        7,908        7,110        7,922        27,637        63,794        100,804        102,180        99,038        365,816        1,150.2   

Kindred Rehabilitation Services:

                     

Kindred Hospital Rehabilitation Services

    25,710        25,742        24,887        23,884        100,223        44,564        44,531        42,141        45,098        176,334        88.8   

RehabCare

    18,016        19,863        17,080        16,029        70,988        16,493        14,681        14,544        11,858        57,576        (26.0
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   
    43,726        45,605        41,967        39,913        171,211        61,057        59,212        56,685        56,956        233,910        42.7   

Nursing center division

    37,572        38,614        35,920        38,810        150,916        36,963        40,461        35,923        36,601        149,948        (5.7

Support center

    (44,456     (48,252     (45,383     (51,348     (189,439     (62,389     (70,209     (55,439     (62,431     (250,468     21.6   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   
  $ 181,044      $ 175,865      $ 157,218      $ 170,088      $ 684,215      $ 234,211      $ 261,800      $ 236,477      $ 247,839      $ 980,327        45.7   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Core EBITDAR margin by segment:

                     

Hospital division

    22.2        21.5        19.9        21.8        21.4        21.0        21.0        16.8        19.8        19.7        (9.2

Kindred at Home:

                     

Home health

    3.8        7.6        8.1        9.9        7.4        15.6        17.0        16.1        16.2        16.3        63.6   

Hospice

    14.3        17.1        9.4        4.2        11.3        14.3        15.7        18.8        16.9        16.6        302.4   

Kindred at Home

    5.4        9.0        8.2        9.1        7.9        15.2        16.6        16.9        16.4        16.4        80.2   

Kindred Rehabilitation Services:

                     

Kindred Hospital Rehabilitation Services

    27.6        27.1        26.7        25.7        26.8        29.4        29.2        28.2        29.0        28.9        12.8   

RehabCare

    7.1        7.8        6.9        6.3        7.0        6.5        6.2        6.6        5.7        6.3        (9.5

Kindred Rehabilitation Services

    12.6        13.1        12.3        11.5        12.4        15.1        15.2        15.4        15.7        15.3        36.5   

Nursing center division

    14.3        14.6        13.6        14.3        14.2        13.5        14.8        13.3        13.4        13.7        (6.3

Consolidated

    14.2        13.9        12.8        13.4        13.6        14.0        14.3        13.4        13.9        13.9        3.7   

 

(a) See reconciliation of core and adjusted results to GAAP results beginning on page 12.
(b) Excludes share dilution from the fourth quarter 2014 common equity and tangible equity units offerings, both pre-closing financing activities of the Gentiva acquisition.

 

- MORE -


Kindred Healthcare Reports Fourth Quarter 2015 Results

Page 9

February 25, 2016

 

 

KINDRED HEALTHCARE, INC.

Condensed Business Segment Data (Continued)

(Unaudited)

(In thousands, except statistics)

 

    2014 Quarters           2015 Quarters           Fourth quarter
% change v.
 
    First     Second     Third     Fourth     Year     First     Second     Third     Fourth     Year     prior year  

Hospital division:

                     

End of period data:

                     

Number of transitional care hospitals

    97        97        97        97          97        96        95        95       

Number of licensed beds

    7,145        7,145        7,145        7,147          7,147        7,124        7,094        7,094       

Revenue mix %:

                     

Medicare

    59.8        58.2        57.0        57.0        58.0        56.8        55.2        57.1        57.3        56.6     

Medicaid

    6.6        6.8        6.9        6.0        6.6        5.5        5.3        5.3        5.1        5.3     

Medicare Advantage

    11.4        11.2        10.5        10.5        10.9        11.9        11.6        10.8        11.1        11.4     

Medicaid Managed

    2.4        3.0        3.8        4.5        3.4        4.7        5.6        6.1        6.2        5.6     

Commercial insurance and other

    19.8        20.8        21.8        22.0        21.1        21.1        22.3        20.7        20.3        21.1     

Admissions:

                     

Medicare

    9,038        8,555        8,460        8,525        34,578        8,775        8,267        7,976        8,169        33,187        (4.2

Medicaid

    819        896        805        750        3,270        610        610        556        520        2,296        (30.7

Medicare Advantage

    1,435        1,389        1,250        1,359        5,433        1,555        1,352        1,212        1,304        5,423        (4.0

Medicaid Managed

    317        381        511        572        1,781        643        675        646        612        2,576        7.0   

Commercial insurance and other

    1,914        1,885        1,703        1,696        7,198        1,868        1,815        1,763        1,701        7,147        0.3   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   
    13,523        13,106        12,729        12,902        52,260        13,451        12,719        12,153        12,306        50,629        (4.6
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Patient days:

                     

Medicare

    230,350        220,035        213,170        220,548        884,103        228,483        218,577        210,870        210,409        868,339        (4.6

Medicaid

    32,712        32,619        30,480        30,454        126,265        28,663        25,213        23,167        21,795        98,838        (28.4

Medicare Advantage

    44,025        43,027        39,938        41,260        168,250        48,448        44,740        39,585        41,079        173,852        (0.4

Medicaid Managed

    10,733        13,191        16,556        20,000        60,480        22,013        24,833        24,412        24,802        96,060        24.0   

Commercial insurance and other

    59,567        59,293        57,486        59,295        235,641        62,241        62,922        58,631        57,321        241,115        (3.3
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   
    377,387        368,165        357,630        371,557        1,474,739        389,848        376,285        356,665        355,406        1,478,204        (4.3
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Average length of stay:

                     

Medicare

    25.5        25.7        25.2        25.9        25.6        26.0        26.4        26.4        25.8        26.2        (0.4

Medicaid

    39.9        36.4        37.9        40.6        38.6        47.0        41.3        41.7        41.9        43.0        3.2   

Medicare Advantage

    30.7        31.0        32.0        30.4        31.0        31.2        33.1        32.7        31.5        32.1        3.6   

Medicaid Managed

    33.9        34.6        32.4        35.0        34.0        34.2        36.8        37.8        40.5        37.3        15.7   

Commercial insurance and other

    31.1        31.5        33.8        35.0        32.7        33.3        34.7        33.3        33.7        33.7        (3.7

Weighted average

    27.9        28.1        28.1        28.8        28.2        29.0        29.6        29.3        28.9        29.2        0.3   

Revenues per admission:

                     

Medicare

  $ 41,492      $ 41,670      $ 39,828      $ 41,425      $ 41,112      $ 41,483      $ 41,892      $ 41,451      $ 41,656      $ 41,620        0.6   

Medicaid

    50,894        46,106        50,344        49,760        49,186        57,594        54,795        55,415        57,724        56,352        16.0   

Medicare Advantage

    49,666        49,352        49,814        47,756        49,142        48,908        53,578        51,495        50,680        51,077        6.1   

Medicaid Managed

    47,803        48,814        44,321        48,691        47,305        46,740        51,950        54,976        60,263        53,383        23.8   

Commercial insurance and other

    64,858        67,679        75,591        80,167        71,743        72,395        77,110        68,151        70,735        72,150        (11.8

Weighted average

    46,384        46,736        46,439        47,991        46,882        47,616        49,312        47,683        48,236        48,209        0.5   

Revenues per patient day:

                     

Medicare

  $ 1,628      $ 1,620      $ 1,581      $ 1,601      $ 1,608      $ 1,593      $ 1,584      $ 1,568      $ 1,617      $ 1,591        1.0   

Medicaid

    1,274        1,266        1,330        1,225        1,274        1,226        1,326        1,330        1,377        1,309        12.4   

Medicare Advantage

    1,619        1,593        1,559        1,573        1,587        1,570        1,619        1,577        1,609        1,593        2.3   

Medicaid Managed

    1,412        1,410        1,368        1,393        1,393        1,365        1,412        1,455        1,487        1,432        6.7   

Commercial insurance and other

    2,084        2,152        2,239        2,293        2,192        2,173        2,224        2,049        2,099        2,139        (8.5

Weighted average

    1,662        1,664        1,653        1,666        1,661        1,643        1,667        1,625        1,670        1,651        0.2   

Medicare case mix index (discharged patients only)

    1.173        1.182        1.157        1.139        1.163        1.166        1.163        1.150        1.164        1.162        2.2   

Average daily census

    4,193        4,046        3,887        4,039        4,040        4,332        4,135        3,877        3,863        4,050        (4.4

Occupancy %

    67.3        64.6        62.1        64.5        64.6        69.2        66.1        62.2        62.2        64.9        (3.6

Same-hospital data:

                     

Revenues (a)

  $ 620,866      $ 606,408      $ 585,553      $ 614,207      $ 2,427,034      $ 634,975      $ 622,018      $ 577,337      $ 594,091      $ 2,428,421        (3.3

Admissions:

                     

Medicare

    8,910        8,423        8,342        8,403        34,078        8,652        8,172        7,932        8,169        32,925        (2.8

Medicaid

    812        885        794        739        3,230        602        608        556        520        2,286        (29.6

Medicare Advantage

    1,429        1,376        1,244        1,351        5,400        1,546        1,348        1,212        1,304        5,410        (3.5

Medicaid Managed

    315        377        511        568        1,771        640        670        644        612        2,566        7.7   

Commercial insurance and other

    1,895        1,863        1,688        1,669        7,115        1,840        1,797        1,762        1,701        7,100        1.9   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   
    13,361        12,924        12,579        12,730        51,594        13,280        12,595        12,106        12,306        50,287        (3.3
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Patient days:

                     

Medicare

    227,635        217,074        210,386        218,127        873,222        225,992        216,230        209,662        210,466        862,350        (3.5

Medicaid

    32,303        32,260        30,254        30,207        125,024        28,458        25,060        23,141        21,795        98,454        (27.8

Medicare Advantage

    43,906        42,802        39,859        41,153        167,720        48,276        44,548        39,585        41,079        173,488        (0.2

Medicaid Managed

    10,714        13,143        16,515        19,906        60,278        21,933        24,673        24,280        24,783        95,669        24.5   

Commercial insurance and other

    59,059        58,968        57,185        58,833        234,045        61,715        62,462        58,625        57,325        240,127        (2.6
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   
    373,617        364,247        354,199        368,226        1,460,289        386,374        372,973        355,293        355,448        1,470,088        (3.5
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Total average length of stay

    28.0        28.2        28.2        28.9        28.3        29.1        29.6        29.3        28.9        29.2        —     

Total revenues per patient day

  $ 1,662      $ 1,665      $ 1,653      $ 1,668      $ 1,662      $ 1,643      $ 1,668      $ 1,625      $ 1,671      $ 1,652        0.2   

 

(a) See reconciliation of same-hospital revenues to reported revenues for the Hospital Division on page 14.

 

- MORE -


Kindred Healthcare Reports Fourth Quarter 2015 Results

Page 10

February 25, 2016

 

 

KINDRED HEALTHCARE, INC.

Condensed Business Segment Data (Continued)

(Unaudited)

(In thousands, except statistics)

 

    2014 Quarters           2015 Quarters           Fourth quarter
% change v.
prior year
 
    First     Second     Third     Fourth     Year     First     Second     Third     Fourth     Year    

Kindred at Home (data combined to include Kindred and Gentiva for each historical period):

                     

Home Health:

                     

Sites of service (at end of period)

    447        440        439        427          415        411        388        373       

Revenue mix %:

                     

Medicare

    81.8        81.5        80.7        80.7        81.2        80.9        80.4        80.0        80.0        80.3     

Medicaid

    2.7        2.6        2.4        2.2        2.5        2.1        2.1        2.1        2.1        2.1     

Commercial and other

    9.1        9.0        8.9        6.7        8.4        7.3        7.9        8.2        8.5        8.1     

Commercial paid at episodic rates

    6.4        6.9        8.0        10.4        7.9        9.7        9.6        9.7        9.4        9.5     

Episodic revenues ($000s)

  $ 281,226      $ 294,208      $ 292,675      $ 305,668      $ 1,173,777      $ 308,317      $ 324,027      $ 319,820      $ 320,698      $ 1,272,862        4.9   

Total episodic admissions

    65,077        63,676        65,049        65,183        258,985        69,936        67,808        66,753        66,157        270,654        1.5   

Medicare episodic admissions

    59,248        58,140        57,921        57,372        232,681        61,186        59,394        58,479        57,804        236,863        0.8   

Total episodes

    103,758        103,689        105,906        106,708        420,061        110,980        109,599        108,519        108,300        437,398        1.5   

Episodes per admission

    1.59        1.63        1.63        1.64        1.62        1.59        1.62        1.63        1.64        1.62        —     

Revenue per episode

  $ 2,710      $ 2,837      $ 2,764      $ 2,865      $ 2,794      $ 2,778      $ 2,956      $ 2,947      $ 2,961      $ 2,910        3.4   

Hospice:

                     

Sites of service (at end of period)

    216        200        199        193          190        185        181        175       

Admissions

    13,807        12,751        12,088        12,151        50,797        13,164        12,574        12,091        12,129        49,958        (0.2

Average length of stay

    103        106        103        103        104        95        93        101        100        97        (2.9

Patient days

    1,252,787        1,251,301        1,236,792        1,215,209        4,956,089        1,150,841        1,190,604        1,211,291        1,185,330        4,738,066        (2.5

Revenue per patient day

  $ 150      $ 148      $ 149      $ 154      $ 150      $ 151      $ 150      $ 150      $ 150      $ 150        (2.6

Average daily census

    13,920        13,751        13,443        13,209        13,578        12,787        13,084        13,166        12,884        12,981        (2.5

Community Care and other revenues (included in Home Health business segment)

  $ 66,732      $ 66,372      $ 67,390      $ 67,621      $ 268,115      $ 65,530      $ 67,647      $ 67,338      $ 67,684      $ 268,199        0.1   

Kindred Rehabilitation Services:

                     

Kindred Hospital Rehabilitation Services:

                     

Freestanding IRFs:

                     

End of period data:

                     

Number of IRFs

    5        5        5        5          16        16        18        18       

Number of licensed beds

    215        215        215        215          829        829        919        919       

Discharges (a)

    1,053        1,121        1,004        1,046        4,224        3,806        3,927        3,941        4,317        15,991        312.7   

Occupancy % (a)

    71.6        71.6        68.5        69.6        70.3        73.2        71.5        68.7        68.0        70.2        (2.3

Average length of stay (a)

    13.2        12.5        13.5        13.2        13.1        13.7        13.1        13.2        12.7        13.2        (3.8

Revenue per discharge (a)

  $ 18,246      $ 17,519      $ 18,259      $ 17,039      $ 17,757      $ 19,517      $ 19,325      $ 18,992      $ 18,640      $ 19,104        9.4   

Contract services:

                     

Sites of service (at end of period):

                     

Inpatient rehabilitation units

    105        104        102        100          100        99        101        100       

LTAC hospitals

    121        118        117        117          120        120        119        119       

Sub-acute units

    10        9        10        10          8        8        7        7       

Outpatient units

    143        143        139        138          138        139        135        130       
 

 

 

   

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   

 

 

   

 

 

     
    379        374        368        365          366        366        362        356       
 

 

 

   

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   

 

 

   

 

 

     

Revenue per site

  $ 195,157      $ 201,400      $ 203,284      $ 205,749      $ 805,590      $ 211,151      $ 209,436      $ 206,041      $ 210,978      $ 837,606        2.5   

RehabCare:

                     

Sites of service (at end of period)

    1,851        1,863        1,896        1,935          1,829        1,789        1,821        1,798       

Revenue per site

  $ 137,193      $ 136,175      $ 130,133      $ 130,576      $ 534,077      $ 138,106      $ 132,359      $ 120,548      $ 114,896      $ 505,909        (12.0

Nursing center division:

                     

End of period data:

                     

Number of nursing centers

    89        89        90        90          90        90        90        90       

Number of licensed beds

    11,503        11,491        11,575        11,535          11,535        11,535        11,535        11,535       

Admissions (b)

    9,789        9,621        9,746        9,616        38,772        10,376        9,831        9,558        9,237        39,002        (3.9

Medicare average length of stay (b)

    29.6        29.8        29.9        29.0        29.6        28.9        28.9        28.5        28.4        28.7        (2.1

Patient days (b)

    861,340        858,772        865,415        871,976        3,457,503        861,278        852,691        851,332        845,924        3,411,225        (3.0

Revenues per patient day (b)

  $ 305      $ 308      $ 305      $ 312      $ 307      $ 319      $ 321      $ 318      $ 323      $ 320        3.5   

Average daily census (b)

    9,570        9,437        9,407        9,478        9,473        9,570        9,370        9,254        9,195        9,346        (3.0

Occupancy % (b)

    81.7        80.7        80.1        80.5        80.7        81.3        79.6        78.6        78.1        79.4        (3.0

 

(a) Excludes non-consolidating IRF.
(b) Excludes managed facilities.

 

- MORE -


Kindred Healthcare Reports Fourth Quarter 2015 Results

Page 11

February 25, 2016

 

 

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, but are not limited to, all statements regarding the Company’s expected future financial position, results of operations, cash flows, dividends, financing plans, business strategy, budgets, capital expenditures, competitive positions, growth opportunities, plans and objectives of management, government investigations, regulatory matters, and statements containing the words such as “anticipate,” “approximate,” “believe,” “plan,” “estimate,” “expect,” “project,” “could,” “would,” “should,” “will,” “intend,” “may,” “potential,” “upside,” and other similar expressions. Statements in this press release concerning the Company’s business outlook or future economic performance, anticipated profitability, revenues, expenses, dividends or other financial items, product or services line growth, and expected outcome of government investigations and other regulatory matters, together with other statements that are not historical facts, are forward-looking statements that are estimates reflecting the best judgment of the Company based upon currently available information.

Such forward-looking statements are inherently uncertain, and stockholders and other potential investors must recognize that actual results may differ materially from the Company’s expectations as a result of a variety of factors. Such forward-looking statements are based upon management’s current expectations and include known and unknown risks, uncertainties and other factors, many of which the Company is unable to predict or control, that may cause the Company’s actual results, performance or plans to differ materially from any future results, performance or plans expressed or implied by such forward-looking statements. These statements involve risks, uncertainties and other factors detailed from time to time in the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K with the Securities and Exchange Commission.

Many of these factors are beyond the Company’s control. The Company cautions investors that any forward-looking statements made by the Company are not guarantees of future performance. The Company disclaims any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments.

 

- MORE -


Kindred Healthcare Reports Fourth Quarter 2015 Results

Page 12

February 25, 2016

 

 

Non-GAAP Measurements

In addition to the results provided in accordance with GAAP, the Company has provided information in this release to compute certain non-GAAP measurements for the four quarters in 2015 and 2014 and for the years ended December 31, 2015 and 2014 before certain charges or on a core and adjusted core basis, and on a same-hospital basis. The use of these non-GAAP measures are not intended to replace the presentation of the Company’s financial results in accordance with GAAP. The Company believes that the presentation of core operating results provides additional information to investors to facilitate the comparison between periods by excluding certain charges that are not representative of its ongoing operations due to the materiality and nature of the charges. The Company believes the presentation of adjusted core operating results, which excludes non-cash expenses related to amortization of intangible assets, stock-based compensation and deferred financing costs from core operating results, is a useful performance measure used by some investors, equity analysts and others to make informed investment decisions and for comparability to other companies that use similar measures. The Company believes the presentation of same-hospital revenues, which excludes the results from two hospitals that closed during 2015, provides investors, equity analysts and others with useful information regarding the performance of the Company’s hospital operations that are comparable for the periods presented. The Company believes that reported hospital segment revenues is the most comparable GAAP measure. Readers of the Company’s financial information should consider reported hospital segment revenues as an important measure of the Company’s Hospital Division financial performance because it provides the most complete measure of its revenues. The Company’s earnings release also includes financial measures referred to as operating income, or EBITDAR or core EBITDAR, and core earnings before interest, income taxes, depreciation and amortization (“core EBITDA”). The Company’s management uses core EBITDAR or core EBITDA as meaningful measures of operational performance in addition to other measures. The Company uses core EBITDAR or core EBITDA to assess the relative performance of its operating divisions as well as the employees that operate these businesses. In addition, the Company believes these measurements are important because securities analysts and investors use these measurements to compare the Company’s performance to other companies in the healthcare industry. The Company believes that income (loss) from continuing operations is the most comparable GAAP measure. Readers of the Company’s financial information should consider income (loss) from continuing operations as an important measure of the Company’s financial performance because it provides the most complete measure of its performance. Operating results presented on a core and adjusted core basis and core EBITDAR or core EBITDA, as well as a same-hospital basis, should be considered in addition to, not as a substitute for, or superior to, financial measures based upon GAAP as an indicator of operating performance. Reconciliations of the non-GAAP measurements to the GAAP measurements are included in the following pages of this press release.

Also in this press release, the Company provides the financial measures of operating cash flows and free cash flows excluding certain items, which the Company refers to as core operating cash flows and core free cash flows. The Company recognizes that core operating cash flows and core free cash flows are non-GAAP measurements and are not intended to replace the presentation of the Company’s cash flows in accordance with GAAP. The Company believes that these non-GAAP measurements provide important information to investors for comparability to other companies that use similar measures. In addition, management uses core operating cash flows and core free cash flows in making decisions related to acquisitions, development capital expenditures, dividends, long-term debt repayments and other uses. The Company believes net cash flows provided by operating activities is the most comparable GAAP measure. Readers of the Company’s financial information should consider net cash flows provided by operating activities as an important measure of the Company’s financial performance because it provides the most complete measure of its performance. Core operating cash flows and core free cash flows should be considered in addition to, not as a substitute for, or superior to, financial measures based upon GAAP as an indicator of operating performance. Reconciliations of net cash flows provided by operating activities to core operating cash flows and core free cash flows are included in this press release.

 

- MORE -


Kindred Healthcare Reports Fourth Quarter 2015 Results

Page 13

February 25, 2016

 

 

KINDRED HEALTHCARE, INC.

Reconciliation of Non-GAAP Measurements to GAAP Results

(Unaudited)

(In thousands, except per share amounts and statistics)

In addition to the results provided in accordance with GAAP, the Company has provided information in this release to compute certain non-GAAP measurements for the three months and years ended December 31, 2015 and 2014 before certain charges or on a core basis. The charges that were excluded from core operating results are denoted in the tables below.

The income tax benefit associated with the excluded charges was calculated using an effective income tax rate of 129.2% and 33.1% for the three months ended December 31, 2015 and 2014, respectively, and 36.8% and 35.4% for the years ended December 31, 2015 and 2014, respectively. The difference in the effective income tax rate for both periods compared to the same prior year periods is attributable to the composition of charges that are non-deductible for income tax purposes. For the three months ended December 31, 2015, the Company recorded an income tax benefit of $47.1 million based upon the final settlement terms of an investigation of RehabCare Group, Inc. by the United States Department of Justice, which was completed in January 2016. The investigation was settled for $126.3 million, including interest, and $125 million of the settlement cost was recorded during the nine months ended September 30, 2015.

 

     Three months ended     Year ended  
     December 31,     December 31,  
     2015     2014     2015     2014  

Detail of charges:

        

Litigation contingency expense

   ($ 8,261   $  —        ($ 138,648   ($ 4,600

Retirement and severance costs

     (2,125     (11,745     (7,752     (18,381

Hospital and home health/hospice closings

     (3,338     (200     (11,127     (200

RehabCare customer contract litigation

     (12,864     —          (12,864     —     

Development project cancellation and other restructuring costs

     —          —          (1,259     —     

RehabCare trade name impairment

     (18,031     —          (18,031     —     

Customer bankruptcy

     —          —          —          (1,857

Consulting fees related to new LTAC criteria rule

     —          (2,460     —          (2,460

Gentiva transaction and integration costs:

        

Professional and consulting fees

     (2,662     (5,545     (37,840     (10,824

Severance and retention

     (1,527     —          (60,358     —     

Lease termination (charged to rent expense)

     —          —          (792     —     

Pre-closing financing charges (charged to general and administrative expenses)

     —          —          (6,005     —     

Pre-closing financing charges (charged to interest expense)

     —          (17,041     (17,431     (17,041

Trade name impairment charges

     —          —          (6,726     —     

Lease termination (charged to rent expense)

     (889     —          (2,720     (247

Debt refinancing costs (charged to interest expense)

     —          —          —          (56,643

Other transaction costs

     (1,178     (3,145     (4,928     (7,159
  

 

 

   

 

 

   

 

 

   

 

 

 
     (50,875     (40,136     (326,481     (119,412

Income tax benefit

     65,738        13,298        120,040        42,234   
  

 

 

   

 

 

   

 

 

   

 

 

 

Charges net of income taxes

     14,863        (26,838     (206,441     (77,178

Allocation to participating unvested restricted stockholders

     (204     —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Available to common stockholders

   $ 14,659      ($ 26,838   ($ 206,441   ($ 77,178
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average diluted shares outstanding

     87,232        65,135        84,558        58,634   
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted earnings (loss) per common share related to charges

   $ 0.17      ($ 0.41   ($ 2.44   ($ 1.32
  

 

 

   

 

 

   

 

 

   

 

 

 

Reconciliation of income from continuing operations before charges:

        

Amounts attributable to Kindred stockholders:

        

Income from continuing operations before charges

   $ 29,039      $ 16,892      $ 112,014      $ 63,202   

Charges net of income taxes

     14,863        (26,838     (206,441     (77,178
  

 

 

   

 

 

   

 

 

   

 

 

 

Reported income (loss) from continuing operations

   $ 43,902      ($ 9,946   ($ 94,427   ($ 13,976
  

 

 

   

 

 

   

 

 

   

 

 

 

Reconciliation of core diluted EPS from continuing operations:

        

Diluted core EPS (a)

   $ 0.33      $ 0.26      $ 1.28      $ 1.06   

Charges net of income taxes

     0.17        (0.41     (2.44     (1.32

Other

     —          —          0.04        0.02   
  

 

 

   

 

 

   

 

 

   

 

 

 

Reported diluted earnings (loss) per common share from continuing operations

   $ 0.50      ($ 0.15   ($ 1.12   ($ 0.24
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average diluted shares used to compute earnings per common share from continuing operations before charges (b)

     87,232        63,163        86,098        58,210   
  

 

 

   

 

 

   

 

 

   

 

 

 

Reconciliation of effective income tax rate before charges:

        

Effective income tax rate before charges

     25.1     27.8     33.3     34.2

Impact of charges on effective income tax rate

     1273.1     22.3     11.9     -25.6
  

 

 

   

 

 

   

 

 

   

 

 

 

Reported effective income tax rate

     1298.2     50.1     45.2     8.6
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) For purposes of computing diluted earnings per common share before charges, income from continuing operations before charges was reduced by $0.4 million for both the three months ended December 31, 2015 and 2014, and by $1.8 million and $1.7 million for the years ended December 31, 2015 and 2014, respectively, for the allocation of income to participating unvested restricted stockholders.
(b) Excludes share dilution from the fourth quarter 2014 common equity and tangible equity units offerings, both pre-closing financing activities of the Gentiva acquisition.

 

- MORE -


Kindred Healthcare Reports Fourth Quarter 2015 Results

Page 14

February 25, 2016

 

 

KINDRED HEALTHCARE, INC.

Reconciliation of Non-GAAP Measurements to GAAP Results (Continued)

(Unaudited)

(In thousands, except per share amounts and statistics)

A reconciliation of adjusted core earnings follows:

 

     2014 Quarters             2015 Quarters         
     First      Second      Third      Fourth      Year      First      Second      Third      Fourth      Year  

Reconciliation of adjusted core earnings:

                             

Income from continuing operations before charges (as calculated and reconciled to GAAP measurement on the following pages)

   $ 18,831       $ 19,363       $ 8,116       $ 16,892       $ 63,202       $ 28,418       $ 34,051       $ 20,506       $ 29,039       $ 112,014   

Add back non-cash expenses:

                             

Amortization of intangible assets

     5,560         5,513         5,378         5,215         21,666         6,932         7,536         7,728         7,645         29,841   

Amortization of stock-based compensation costs

     2,585         5,924         748         5,073         14,330         3,141         6,687         3,194         4,778         17,800   

Amortization of deferred financing costs

     2,397         1,950         1,982         2,044         8,373         3,062         3,539         3,554         3,566         13,721   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     10,542         13,387         8,108         12,332         44,369         13,135         17,762         14,476         15,989         61,362   

Income tax benefit related to non-cash expenses

     4,148         5,268         3,190         4,853         17,459         5,169         6,989         5,696         6,292         24,146   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Non-cash expenses, net of income taxes

     6,394         8,119         4,918         7,479         26,910         7,966         10,773         8,780         9,697         37,216   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted core earnings

   $ 25,225       $ 27,482       $ 13,034       $ 24,371       $ 90,112       $ 36,384       $ 44,824       $ 29,286       $ 38,736       $ 149,230   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Reconciliation of diluted adjusted core earnings from continuing operations:

                             

Diluted income per common share before charges (as calculated on the following pages)

   $ 0.35       $ 0.35       $ 0.13       $ 0.26       $ 1.06       $ 0.34       $ 0.39       $ 0.23       $ 0.33       $ 1.28   

Non-cash expenses, net of income taxes

     0.11         0.15         0.07         0.12         0.45         0.09         0.12         0.10         0.11         0.42   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted diluted core EPS from continuing operations

   $ 0.46       $ 0.50       $ 0.20       $ 0.38       $ 1.51       $ 0.43       $ 0.51       $ 0.33       $ 0.44       $ 1.70   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Weighted average diluted shares used to compute adjusted core EPS

     52,711         53,792         62,902         63,163         58,210         82,422         86,402         86,892         87,232         86,098   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

A reconciliation of combined Kindred and Gentiva home health revenues (excluding community care) for each historical period follows:

 

     2014 Quarters             2015 Quarters             Fourth quarter
% change v.
prior year
 
     First      Second      Third      Fourth      Year      First      Second      Third      Fourth      Year     

Kindred

   $ 67,266       $ 67,830       $ 65,954       $ 66,491       $ 267,541       $ 254,965       $ 360,173       $ 356,716       $ 358,075       $ 1,329,929      

Gentiva

     253,895         267,018         266,340         275,342         1,062,595         87,520         —           —           —           87,520      
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    
   $ 321,161       $ 334,848       $ 332,294       $ 341,833       $ 1,330,136       $ 342,485       $ 360,173       $ 356,716       $ 358,075       $ 1,417,449         4.8   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

A reconciliation of same-hospital revenues to reported revenues for the Hospital Division for each historical period follows:

 

     2014 Quarters             2015 Quarters            Fourth quarter
% change v.
prior year
 
     First      Second      Third      Fourth      Year      First      Second      Third      Fourth     Year     

Same-hospital revenues

   $ 620,866       $ 606,408       $ 585,553       $ 614,207       $ 2,427,034       $ 634,975       $ 622,018       $ 577,337       $ 594,091      $ 2,428,421         (3.3

Two hospitals that closed during 2015 (a)

     6,379         6,109         5,568         4,978         23,034         5,508         5,188         2,160         (498     12,358      
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

   

 

 

    

Reported revenues

   $ 627,245       $ 612,517       $ 591,121       $ 619,185       $ 2,450,068       $ 640,483       $ 627,206       $ 579,497       $ 593,593      $ 2,440,779         (4.1
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

   

 

 

    

 

(a) One hospital closed during the second quarter of 2015 and one hospital closed during the third quarter of 2015.

 

- MORE -


Kindred Healthcare Reports Fourth Quarter 2015 Results

Page 15

February 25, 2016

 

 

KINDRED HEALTHCARE, INC.

Reconciliation of Non-GAAP Measurements to GAAP Results (Continued)

(Unaudited)

(In thousands, except per share amounts)

 

     Three months ended December 31, 2015  
           Charges        
                 Hospital     RehabCare                 Gentiva                    
     Before     Retirement     and home     customer                 transaction                    
     charges     and     health/hospice     contract     Litigation     Impairment     and     Other           As  
     (“core”)     severance     closings     litigation     contingency     charges     integration     transaction     Total     reported  

Income from continuing operations:

                    

Operating income (loss) (EBITDAR):

                    

Hospital division

   $ 117,675      $ (1,221   $  —        $  —        $  —        $  —        $  —        $  —        $ (1,221   $ 116,454   

Kindred at Home:

                    

Home health

     68,826        —          (1,794     —          —          —          —          —          (1,794     67,032   

Hospice

     30,212        —          (1,544     —          —          —          —          —          (1,544     28,668   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     99,038        —          (3,338     —          —          —          —          —          (3,338     95,700   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Kindred Rehabilitation Services:

                    

Kindred Hospital Rehabilitation Services

     45,098        (207     —          —          —          —          —          —          (207     44,891   

RehabCare

     11,858        (112     —          (12,864     —          —          —          —          (12,976     (1,118
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     56,956        (319     —          (12,864     —          —          —          —          (13,183     43,773   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Nursing center division

     36,601        —          —          —          —          —          —          —          —          36,601   

Support center

     (62,431     (585     —          —          —          —          —          —          (585     (63,016

Litigation contingency expense

     —          —          —          —          (8,261       —          —          (8,261     (8,261

Impairment charges

     —          —          —          —          —          (18,031     —          —          (18,031     (18,031

Transaction costs

     —          —          —          —          —          —          (4,189     (1,178     (5,367     (5,367
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income (EBITDAR)

     247,839        (2,125     (3,338     (12,864     (8,261     (18,031     (4,189     (1,178     (49,986     197,853   

Rent

     (96,934     —          (889     —          —          —          —          —          (889     (97,823
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

EBITDA

     150,905        (2,125     (4,227     (12,864     (8,261     (18,031     (4,189     (1,178     (50,875     100,030   

Depreciation and amortization

     (40,362     —          —          —          —          —          —          —          —          (40,362

Interest, net

     (55,664     —          —          —          —          —          —          —          —          (55,664
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations before income taxes

     54,879        (2,125     (4,227     (12,864     (8,261     (18,031     (4,189     (1,178     (50,875     4,004   

Provision (benefit) for income taxes

     13,758        (836     (1,663     (5,062     (50,329     (6,205     (1,487     (156     (65,738     (51,980
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     41,121      $ (1,289   $ (2,564   $ (7,802   $ 42,068      $ (11,826   $ (2,702   $ (1,022   $ 14,863        55,984   
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Noncontrolling interests

     (12,082                     (12,082
  

 

 

                   

 

 

 

Income attributable to Kindred

   $ 29,039                      $ 43,902   
  

 

 

                   

 

 

 

Diluted earnings per common share

   $ 0.33                      $ 0.50   

Diluted shares used in computing earnings per common share

     87,232                        87,232   

 

     Three months ended December 31, 2014  
           Charges        
     Before     Severance     LTAC     Gentiva                          
     charges     and other     criteria     pre-closing     Gentiva     Other           As  
     (“core”)     restructuring     consulting     financing     transaction     transaction     Total     reported  

Income (loss) from continuing operations:

                

Operating income (loss) (EBITDAR):

                

Hospital division

   $ 134,791      $ (318   $ —        $ —        $ —        $ —        $ (318   $ 134,473   

Kindred at Home:

                

Home health

     7,398        (828     —          —          —          —          (828     6,570   

Hospice

     524        (106     —          —          —          —          (106     418   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     7,922        (934     —          —          —          —          (934     6,988   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Kindred Rehabilitation Services:

                

Kindred Hospital Rehabilitation Services

     23,884        —          —          —          —          —          —          23,884   

RehabCare

     16,029        —          —          —          —          —          —          16,029   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     39,913        —          —          —          —          —          —          39,913   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Nursing center division

     38,810        (500     —          —          —          —          (500     38,310   

Support center

     (51,348     (10,193     (2,460     —          —          —          (12,653     (64,001

Transaction costs

     —          —          —          —          (5,545     (3,145     (8,690     (8,690
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income (EBITDAR)

     170,088        (11,945     (2,460     —          (5,545     (3,145     (23,095     146,993   

Rent

     (79,167     —          —          —          —          —          —          (79,167
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

EBITDA

     90,921        (11,945     (2,460     —          (5,545     (3,145     (23,095     67,826   

Depreciation and amortization

     (38,558     —          —          —          —          —          —          (38,558

Interest, net

     (21,857     —          —          (17,041     —          —          (17,041     (38,898
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

     30,506        (11,945     (2,460     (17,041     (5,545     (3,145     (40,136     (9,630

Provision (benefit) for income taxes

     8,471        (4,251     (875     (5,975     (1,514     (683     (13,298     (4,827
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     22,035      $ (7,694   $ (1,585   $ (11,066   $ (4,031   $ (2,462   $ (26,838     (4,803
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Noncontrolling interests

     (5,143                 (5,143
  

 

 

               

 

 

 

Income (loss) attributable to Kindred

   $ 16,892                  $ (9,946
  

 

 

               

 

 

 

Diluted earnings (loss) per common share

   $ 0.26                  $ (0.15

Diluted shares used in computing earnings (loss) per common share

     63,163                    65,135   

 

- MORE -


Kindred Healthcare Reports Fourth Quarter 2015 Results

Page 16

February 25, 2016

 

 

KINDRED HEALTHCARE, INC.

Reconciliation of Non-GAAP Measurements to GAAP Results (Continued)

(Unaudited)

(In thousands, except per share amounts)

 

    Year ended December 31, 2015  
          Charges        
                Hospital     Development     RehabCare                 Gentiva     Gentiva                    
    Before     Retirement     and home     project     customer                 pre-closing     transaction                    
    charges     and     health/hospice     cancellation     contract     Litigation     Impairment     financing     and     Other           As  
    (“core”)     severance     closings     and other     litigation     contingency     charges     costs     integration     transaction     Total     reported  

Income (loss) from continuing operations:

                       

Operating income (loss) (EBITDAR):

                       

Hospital division

  $ 481,121      $ (1,887   $ (1,044   $ (675   $ —        $ —        $ —        $ —        $ —        $ —        $ (3,606   $ 477,515   

Kindred at Home:

                       

Home health

    256,696        —          (6,055     —          —          —          —          —          —          —          (6,055     250,641   

Hospice

    109,120        —          (4,028     —          —          —          —          —          —          —          (4,028     105,092   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    365,816        —          (10,083     —          —          —          —          —          —          —          (10,083     355,733   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Kindred Rehabilitation Services:

                       

Kindred Hospital Rehabilitation Services

    176,334        (207     —          —          —          —          —          —          —          —          (207     176,127   

RehabCare

    57,576        (897     —          —          (12,864     —          —          —          —          —          (13,761     43,815   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    233,910        (1,104     —          —          (12,864     —          —          —          —          —          (13,968     219,942   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Nursing center division

    149,948        —          —          (584     —          —          —          —          —          —          (584     149,364   

Support center

    (250,468     (4,761     —          —          —          —          —          —          —          —          (4,761     (255,229

Litigation contingency expense

    —          —          —          —          —          (138,648     —          —          —          —          (138,648     (138,648

Impairment charges

    —          —          —          —          —          —          (24,757     —          —          —          (24,757     (24,757

Transaction costs

    —          —          —          —          —          —          —          (6,005     (98,198     (4,928     (109,131     (109,131
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income (EBITDAR)

    980,327        (7,752     (11,127     (1,259     (12,864     (138,648     (24,757     (6,005     (98,198     (4,928     (305,538     674,789   

Rent

    (379,097     —          (2,368     (352     —          —          —          —          (792     —          (3,512     (382,609
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

EBITDA

    601,230        (7,752     (13,495     (1,611     (12,864     (138,648     (24,757     (6,005     (98,990     (4,928     (309,050     292,180   

Depreciation and amortization

    (157,251     —          —          —          —          —          —          —          —          —          —          (157,251

Interest, net

    (212,158     —          —          —          —          —          —          (17,431     —          —          (17,431     (229,589
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

    231,821        (7,752     (13,495     (1,611     (12,864     (138,648     (24,757     (23,436     (98,990     (4,928     (326,481     (94,660

Provision for income taxes

    77,243        (3,063     (5,333     (637     (5,084     (51,965     (8,890     (9,261     (34,266     (1,541     (120,040     (42,797
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    154,578      $ (4,689   $ (8,162   $ (974   $ (7,780   $ (86,683   $ (15,867   $ (14,175   $ (64,724   $ (3,387   $ (206,441     (51,863
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Noncontrolling interests

    (42,564                         (42,564
 

 

 

                       

 

 

 

Income (loss) attributable to Kindred

  $ 112,014                          $ (94,427
 

 

 

                       

 

 

 

Diluted earnings (loss) per common share

  $ 1.28                          $ (1.12

Diluted shares used in computing earnings (loss) per common share

    86,098                            84,558   

 

     Year ended December 31, 2014  
           Charges        
     Before     Severance     LTAC                       Gentiva                          
     charges     and other     criteria     Customer     Litigation     Debt     pre-closing     Gentiva     Other           As  
     (“core”)     restructuring     consulting     bankruptcy     contingency     refinancing     financing     transaction     transaction     Total     reported  

Income (loss) from continuing operations:

                      

Operating income (loss) (EBITDAR):

                      

Hospital division

   $ 523,890      $ (935   $  —        $  —        $  —        $  —        $  —        $  —        $  —        $ (935   $ 522,955   

Kindred at Home:

                      

Home health

     21,973        (1,824     —          —          —          —          —          —          —          (1,824     20,149   

Hospice

     5,664        (274     —          —          —          —          —          —          —          (274     5,390   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     27,637        (2,098     —          —          —          —          —          —          —          (2,098     25,539   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Kindred Rehabilitation Services:

                      

Kindred Hospital Rehabilitation Services

     100,223        (170     —          (1,857     —          —          —          —          —          (2,027     98,196   

RehabCare

     70,988        (14     —          —          —          —          —          —          —          (14     70,974   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     171,211        (184     —          (1,857     —          —          —          —          —          (2,041     169,170   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Nursing center division

     150,916        (4,188     —          —          —          —          —          —          —          (4,188     146,728   

Support center

     (189,439     (11,176     (2,460     —          —          —          —          —          —          (13,636     (203,075

Litigation contingency expense

     —          —            —          (4,600             (4,600     (4,600

Transaction costs

     —          —          —          —          —          —          —          (10,824     (7,159     (17,983     (17,983
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income (EBITDAR)

     684,215        (18,581     (2,460     (1,857     (4,600     —          —          (10,824     (7,159     (45,481     638,734   

Rent

     (312,792     (247     —          —          —          —          —          —          —          (247     (313,039
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

EBITDA

     371,423        (18,828     (2,460     (1,857     (4,600     —          —          (10,824     (7,159     (45,728     325,695   

Depreciation and amortization

     (155,570     —          —          —          —          —          —          —          —          —          (155,570

Interest, net

     (91,083     —          —          —          —          (56,643     (17,041     —          —          (73,684     (164,767
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations before income taxes

     124,770        (18,828     (2,460     (1,857     (4,600     (56,643     (17,041     (10,824     (7,159     (119,412     5,358   

Provision for income taxes

     42,696        (7,156     (935     (706     (1,748     (21,528     (6,381     (1,665     (2,115     (42,234     462   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     82,074      $ (11,672   $ (1,525   $ (1,151   $ (2,852   $ (35,115   $ (10,660   $ (9,159   $ (5,044   $ (77,178     4,896   
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Noncontrolling interests

     (18,872                       (18,872
  

 

 

                     

 

 

 

Income (loss) attributable to Kindred

   $ 63,202                        $ (13,976
  

 

 

                     

 

 

 

Diluted earnings (loss) per common share

   $ 1.06                        $ (0.24

Diluted shares used in computing earnings (loss) per common share

     58,210                          58,634   

 

- MORE -


Kindred Healthcare Reports Fourth Quarter 2015 Results

Page 17

February 25, 2016

 

 

KINDRED HEALTHCARE, INC.

Reconciliation of Non-GAAP Measurements to GAAP Results (Continued)

(Unaudited)

(In thousands, except per share amounts)

 

    Three months ended March 31, 2015  
          Charges        
                Home health     Development                 Gentiva     Gentiva                    
    Before     Retirement     and     project                 pre-closing     transaction                    
    charges     and     hospice     cancellation     Litigation     Impairment     financing     and     Other           As  
    (“core”)     severance     closings     and other     contingency     charges     costs     integration     transaction     Total     reported  

Income (loss) from continuing operations:

                     

Operating income (loss) (EBITDAR):

                     

Hospital division

  $ 134,786      $  —        $  —        $ (675   $  —        $  —        $  —        $  —        $  —        $ (675   $ 134,111   

Kindred at Home:

                     

Home health

    46,798        —          (1,102     —          —          —          —          —          —          (1,102     45,696   

Hospice

    16,996        —          (517     —          —          —          —          —          —          (517     16,479   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    63,794        —          (1,619     —          —          —          —          —          —          (1,619     62,175   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Kindred Rehabilitation Services:

                     

Kindred Hospital Rehabilitation Services

    44,564        —          —          —          —          —          —          —          —          —          44,564   

RehabCare

    16,493        (785     —          —          —          —          —          —          —          (785     15,708   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    61,057        (785     —          —          —          —          —          —          —          (785     60,272   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Nursing center division

    36,963        —          —          —          —          —          —          —          —          —          36,963   

Support center

    (62,389     (4,176     —          —          —          —          —          —          —          (4,176     (66,565

Litigation contingency expense

    —          —          —          —          (95,000     —          —          —          —          (95,000     (95,000

Impairment charges

    —          —          —          —          —          (6,726     —          —          —          (6,726     (6,726

Transaction costs

    —          —          —          —          —          —          (6,005     (86,598     (2,099     (94,702     (94,702
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income (EBITDAR)

    234,211        (4,961     (1,619     (675     (95,000     (6,726     (6,005     (86,598     (2,099     (203,683     30,528   

Rent

    (91,199     —          —          (352     —          —          —          (589     —          (941     (92,140
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

EBITDA

    143,012        (4,961     (1,619     (1,027     (95,000     (6,726     (6,005     (87,187     (2,099     (204,624     (61,612

Depreciation and amortization

    (38,935     —          —          —          —          —          —          —          —          —          (38,935

Interest, net

    (44,346     —          —          —          —          —          (17,431     —          —          (17,431     (61,777
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

    59,731        (4,961     (1,619     (1,027     (95,000     (6,726     (23,436     (87,187     (2,099     (222,055     (162,324

Provision (benefit) for income taxes

    22,466        (2,133     (696     (442     —          (2,891     (10,075     (33,063     (902     (50,202     (27,736
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    37,265      $ (2,828   $ (923   $ (585   $ (95,000   $ (3,835   $ (13,361   $ (54,124   $ (1,197   $ (171,853     (134,588
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Noncontrolling interests

    (8,847                       (8,847
 

 

 

                     

 

 

 

Income (loss) attributable to Kindred

  $ 28,418                        $ (143,435
 

 

 

                     

 

 

 

Diluted earnings (loss) per common share

  $ 0.34                        $ (1.80

Diluted shares used in computing earnings (loss) per common share

    82,422                          79,575   

 

     Three months ended March 31, 2014  
     Before      Charges         
     charges      Transaction      As  
     (“core”)      costs      reported  

Income from continuing operations:

        

Operating income (loss) (EBITDAR):

        

Hospital division

   $ 139,505       $  —         $ 139,505   

Kindred at Home:

        

Home health

     2,845         —           2,845   

Hospice

     1,852         —           1,852   
  

 

 

    

 

 

    

 

 

 
     4,697         —           4,697   
  

 

 

    

 

 

    

 

 

 

Kindred Rehabilitation Services:

        

Kindred Hospital Rehabilitation Services

     25,710         —           25,710   

RehabCare

     18,016         —           18,016   
  

 

 

    

 

 

    

 

 

 
     43,726         —           43,726   
  

 

 

    

 

 

    

 

 

 

Nursing center division

     37,572         —           37,572   

Support center

     (44,456      —           (44,456

Transaction costs

     —           (683      (683
  

 

 

    

 

 

    

 

 

 

Operating income (EBITDAR)

     181,044         (683      180,361   

Rent

     (78,530      —           (78,530
  

 

 

    

 

 

    

 

 

 

EBITDA

     102,514         (683      101,831   

Depreciation and amortization

     (39,092      —           (39,092

Interest, net

     (25,617      —           (25,617
  

 

 

    

 

 

    

 

 

 

Income from continuing operations before income taxes

     37,805         (683      37,122   

Provision for income taxes

     14,445         (250      14,195   
  

 

 

    

 

 

    

 

 

 
     23,360       $ (433      22,927   
     

 

 

    

Noncontrolling interests

     (4,529         (4,529
  

 

 

       

 

 

 

Income attributable to Kindred

   $ 18,831          $ 18,398   
  

 

 

       

 

 

 

Diluted earnings per common share

   $ 0.35          $ 0.34   

Diluted shares used in computing earnings per common share

     52,711            52,711   

 

- MORE -


Kindred Healthcare Reports Fourth Quarter 2015 Results

Page 18

February 25, 2016

 

 

KINDRED HEALTHCARE, INC.

Reconciliation of Non-GAAP Measurements to GAAP Results (Continued)

(Unaudited)

(In thousands, except per share amounts)

 

     Three months ended June 30, 2015  
           Charges        
     Before
charges
(“core”)
    Hospital
and home
health/hospice
closings
    Development
project
cancellation
and other
    Litigation
contingency
    Gentiva
transaction
and
integration
    Other
transaction
    Total     As
reported
 
                
                
                

Income from continuing operations:

                

Operating income (loss) (EBITDAR):

                

Hospital division

   $ 131,532      $ (565   $  —        $  —        $  —        $  —        $ (565   $ 130,967   

Kindred at Home:

                

Home health

     72,917        (588     —          —          —          —          (588     72,329   

Hospice

     27,887        (1,649     —          —          —          —          (1,649     26,238   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     100,804        (2,237     —          —          —          —          (2,237     98,567   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Kindred Rehabilitation Services:

                

Kindred Hospital Rehabilitation Services

     44,531        —          —          —          —          —          —          44,531   

RehabCare

     14,681        —          —          —          —          —          —          14,681   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     59,212        —          —          —          —          —          —          59,212   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Nursing center division

     40,461        —          (584     —          —          —          (584     39,877   

Support center

     (70,209     —          —          —          —          —          —          (70,209

Litigation contingency expense

     —          —          —          (3,925     —          —          (3,925     (3,925

Transaction costs

     —          —          —          —          (4,342     (874     (5,216     (5,216
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income (EBITDAR)

     261,800        (2,802     (584     (3,925     (4,342     (874     (12,527     249,273   

Rent

     (95,528     (671     —          —          (203     —          (874     (96,402
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

EBITDA

     166,272        (3,473     (584     (3,925     (4,545     (874     (13,401     152,871   

Depreciation and amortization

     (38,625     —          —          —          —          —          —          (38,625

Interest, net

     (56,140     —          —          —          —          —          —          (56,140
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations before income taxes

     71,507        (3,473     (584     (3,925     (4,545     (874     (13,401     58,106   

Provision for income taxes

     25,721        (368     (62     (416     (386     (93     (1,325     24,396   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     45,786      $ (3,105   $ (522   $ (3,509   $ (4,159   $ (781   $ (12,076     33,710   
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Noncontrolling interests

     (11,735                 (11,735
  

 

 

               

 

 

 

Income attributable to Kindred

   $ 34,051                  $ 21,975   
  

 

 

               

 

 

 

Diluted earnings per common share

   $ 0.39                  $ 0.25   

Diluted shares used in computing earnings per common share

     86,402                    86,402   

 

     Three months ended June 30, 2014  
           Charges        
     Before
charges
(“core”)
    Severance
and other
restructuring
    Litigation
contingency
    Debt
refinancing
    Gentiva
transaction
    Other
transaction
    Total     As
reported
 
                
                

Income (loss) from continuing operations:

                

Operating income (loss) (EBITDAR):

                

Hospital division

   $ 131,990      $  —        $  —        $  —        $  —        $  —        $  —        $ 131,990   

Kindred at Home:

                

Home health

     5,769        (721     —          —          —          —          (721     5,048   

Hospice

     2,139        (122     —          —          —          —          (122     2,017   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     7,908        (843     —          —          —          —          (843     7,065   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Kindred Rehabilitation Services:

                

Kindred Hospital Rehabilitation Services

     25,742        (170     —          —          —          —          (170     25,572   

RehabCare

     19,863        (176     —          —          —          —          (176     19,687   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     45,605        (346     —          —          —          —          (346     45,259   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Nursing center division

     38,614        (3,205     —          —          —          —          (3,205     35,409   

Support center

     (48,252     (556     —          —          —          —          (556     (48,808

Litigation contingency expense

     —          —          (4,600     —          —          —          (4,600     (4,600

Transaction costs

     —          —          —          —          (2,079     (2,417     (4,496     (4,496
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income (EBITDAR)

     175,865        (4,950     (4,600     —          (2,079     (2,417     (14,046     161,819   

Rent

     (77,452     (247     —          —          —          —          (247     (77,699
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

EBITDA

     98,413        (5,197     (4,600     —          (2,079     (2,417     (14,293     84,120   

Depreciation and amortization

     (39,172     —          —          —          —          —          —          (39,172

Interest, net

     (21,438     —          —          (56,643     —          —          (56,643     (78,081
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from continuing operations before income taxes

     37,803        (5,197     (4,600     (56,643     (2,079     (2,417     (70,936     (33,133

Provision (benefit) for income taxes

     13,612        (1,985     (1,757     (21,639     —          (914     (26,295     (12,683
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     24,191      $ (3,212   $ (2,843   $ (35,004   $ (2,079   $ (1,503   $ (44,641     (20,450
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Noncontrolling interests

     (4,828                 (4,828
  

 

 

               

 

 

 

Income (loss) attributable to Kindred

   $ 19,363                  $ (25,278
  

 

 

               

 

 

 

Diluted earnings (loss) per common share

   $ 0.35                  $ (0.47

Diluted shares used in computing earnings (loss) per common share

     53,792                    53,714   

 

- MORE -


Kindred Healthcare Reports Fourth Quarter 2015 Results

Page 19

February 25, 2016

 

 

KINDRED HEALTHCARE, INC.

Reconciliation of Non-GAAP Measurements to GAAP Results (Continued)

(Unaudited)

(In thousands, except per share amounts)

 

     Three months ended September 30, 2015  
           Charges        
     Before
charges
(“core”)
    Retirement
and
severance
    Hospital
and home
health/hospice
closings
    Litigation
contingency
    Gentiva
transaction
and
integration
    Other
transaction
    Total     As
reported
 

Income (loss) from continuing operations:

                

Operating income (loss) (EBITDAR):

                

Hospital division

   $ 97,128      $ (666   $ (479   $  —        $  —        $  —        $ (1,145   $ 95,983   

Kindred at Home:

                

Home health

     68,155        —          (2,571     —          —          —          (2,571     65,584   

Hospice

     34,025        —          (318     —          —          —          (318     33,707   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     102,180        —          (2,889     —          —          —          (2,889     99,291   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Kindred Rehabilitation Services:

                

Kindred Hospital Rehabilitation Services

     42,141        —          —          —          —          —          —          42,141   

RehabCare

     14,544        —          —          —          —          —          —          14,544   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     56,685        —          —          —          —          —          —          56,685   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Nursing center division

     35,923        —          —          —          —          —          —          35,923   

Support center

     (55,439     —          —          —          —          —          —          (55,439

Litigation contingency expense

     —          —          —          (31,462     —          —          (31,462     (31,462

Transaction costs

     —          —          —          —          (3,069     (777     (3,846     (3,846
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income (EBITDAR)

     236,477        (666     (3,368     (31,462     (3,069     (777     (39,342     197,135   

Rent

     (95,436     —          (808     —          —          —          (808     (96,244
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

EBITDA

     141,041        (666     (4,176     (31,462     (3,069     (777     (40,150     100,891   

Depreciation and amortization

     (39,329     —          —          —          —          —          —          (39,329

Interest, net

     (56,008     —          —          —          —          —          —          (56,008
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations before income taxes

     45,704        (666     (4,176     (31,462     (3,069     (777     (40,150     5,554   

Provision for income taxes

     15,298        (196     (1,225     (429     (697     (228     (2,775     12,523   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     30,406      $ (470   $ (2,951   $ (31,033   $ (2,372   $ (549   $ (37,375     (6,969
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Noncontrolling interests

     (9,900                 (9,900
  

 

 

               

 

 

 

Income (loss) attributable to Kindred

   $ 20,506                  $ (16,869
  

 

 

               

 

 

 

Diluted earnings (loss) per common share

   $ 0.23                  $ (0.20

Diluted shares used in computing earnings (loss) per common share

     86,892                    86,184   

 

     Three months ended September 30, 2014  
           Charges        
     Before     Severance                                
     charges     and other     Customer     Gentiva     Other           As  
     (“core”)     restructuring     bankruptcy     transaction     transaction     Total     reported  

Income from continuing operations:

              

Operating income (loss) (EBITDAR):

              

Hospital division

   $ 117,604      $ (617   $  —        $  —        $  —        $ (617   $ 116,987   

Kindred at Home:

              

Home health

     5,961        (275     —          —          —          (275     5,686   

Hospice

     1,149        (46     —          —          —          (46     1,103   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     7,110        (321     —          —          —          (321     6,789   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Kindred Rehabilitation Services:

              

Kindred Hospital Rehabilitation Services

     24,887        —          (1,857     —          —          (1,857     23,030   

RehabCare

     17,080        162        —          —          —          162        17,242   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     41,967        162        (1,857     —          —          (1,695     40,272   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Nursing center division

     35,920        (483     —          —          —          (483     35,437   

Support center

     (45,383     (427     —          —          —          (427     (45,810

Transaction costs

     —          —          —          (3,200     (914     (4,114     (4,114
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income (EBITDAR)

     157,218        (1,686     (1,857     (3,200     (914     (7,657     149,561   

Rent

     (77,643     —          —          —          —          —          (77,643
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

EBITDA

     79,575        (1,686     (1,857     (3,200     (914     (7,657     71,918   

Depreciation and amortization

     (38,748     —          —          —          —          —          (38,748

Interest, net

     (22,171     —          —          —          —          —          (22,171
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations before income taxes

     18,656        (1,686     (1,857     (3,200     (914     (7,657     10,999   

Provision for income taxes

     6,168        (923     (1,017     (69     (382     (2,391     3,777   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     12,488      $ (763   $ (840   $ (3,131   $ (532   $ (5,266     7,222   
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Noncontrolling interests

     (4,372               (4,372
  

 

 

             

 

 

 

Income attributable to Kindred

   $ 8,116                $ 2,850   
  

 

 

             

 

 

 

Diluted earnings per common share

   $ 0.13                $ 0.04   

Diluted shares used in computing earnings per common share

     62,902                  62,902   

 

- MORE -


Kindred Healthcare Reports Fourth Quarter 2015 Results

Page 20

February 25, 2016

 

 

KINDRED HEALTHCARE, INC.

Reconciliation of Non-GAAP Measurements to GAAP Results (Continued)

(Unaudited)

(In thousands)

 

     Three months ended      Year ended  
     December 31,      December 31,  
     2015      2014      2015      2014  

Reconciliation of net cash flows provided by operating activities to free cash flows:

           

Net cash flows provided by operating activities

   $ 70,195       $ 81,149       $ 163,262       $ 105,471   

Adjustments to remove certain payments (including payments made for discontinued operations) included in net cash flows provided by operating activities:

           

Transaction, severance, retirement and retention

     4,548         10,516         106,648         25,906   

Ventas, Inc. lease termination fee

     —           —           40,000         —     

Ventas, Inc. lease maintenance payment

     —           2,500         —           2,500   

Capitalized lender fees related to debt refinancing

     —           3,527         28,012         22,652   

Other debt refinancing costs (expensed)

     —           —           40,439         40,373   

Other lease termination fees

     —           —           353         —     

Litigation

     —           —           16,575         25,850   
  

 

 

    

 

 

    

 

 

    

 

 

 
     4,548         16,543         232,027         117,281   
  

 

 

    

 

 

    

 

 

    

 

 

 

Net cash flows provided by operating activities excluding certain items before income tax benefit of certain payments

     74,743         97,692         395,289         222,752   

Benefit of reduced income tax payments resulting from certain payments

     (20,861      (12,055      (77,156      (34,912
  

 

 

    

 

 

    

 

 

    

 

 

 

Net cash flows provided by operating activities excluding certain items (core operating cash flows) (a)

     53,882         85,637         318,133         187,840   

Less routine capital expenditures

     (41,240      (23,656      (121,931      (91,081

Less distributions to noncontrolling interests

     (10,635      (4,088      (42,458      (13,692
  

 

 

    

 

 

    

 

 

    

 

 

 

Free cash flows excluding certain items (core free cash flows)

   $ 2,007       $ 57,893       $ 153,744       $ 83,067   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(a) Includes federal income tax refunds of $29 million and $35 million received for the years ended December 31, 2015 and 2014, respectively. The Company made no federal income tax payments for the years ended December 31, 2015 or 2014.    

 

- END -